emjreviews.com37m
The Future of Food Allergy: Interview with Hugh Sampson
What initially drew you to the field of allergy and immunology, and how did your focus come to centre on food allergic ...
Swedish Orphan Biovitrum AB: US FDA grants Priority Review to Sobi's supplemental Biologics Licence Application (sBLA) for Gamifant (emapalumab-lzsg)
Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) ...